Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ëÀå¾ÏÀÇ °£ÀüÀÌ¿¡ ´ëÇÑ Ä¡·á: 99¿¹ÀÇ ÈÄÇâÀû ºñ±³ºÐ¼® Treatment of Hepatic Metastasis of Colorectal Cancer: A Retrospective Analysis of the Outcome in 99 Patients

´ëÇѾÏÇÐȸÁö 1998³â 30±Ç 6È£ p.1175 ~ 1183
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁøõ/Jin Cheon Kim ±èâ³²/À¯Ã¢½Ä/ÀÌÇÑÀÏ/±è»óÀ§/ÀÌÁ¦È¯/±è¿ì°Ç/°­°æÈÆ/À̹®±Ô/Chang Nam Kim/Chang Sik Yu/Han Il Lee/Sang We Kim/Je Hwan Lee/Woo Kun Kim/Gyeong Hoon Kang/Moon Kyu Lee

Abstract

¼­·Ð
´ëÀå¾ÏÀÇ ±ÙÄ¡¼ö¼úÈÄ ¿Ü·¡Áø·á»ó Ç÷û CEA¼ö°¡ Áõ°¡Çϸé CT ¹× MRI¿¡¼­ °£ÀüÀ̸¦ ºó
¹øÇÏ°Ô ¹ß°ßÇÏ°Ô µÈ´Ù. ÀÌ¿Í°°ÀÌ ´ëÀå¾Ï¿¡¼­ °¡Àå ÈçÇÑ ÀüÀÌ´Â °£À¸·Î ¾Ë·ÁÁ® ÀÖ°í, ´ëÀå¾Ï
¼ö¼úÈÄ Àç¹ßµÇ´Â ȯÀÚÀÇ 2/3¿¡¼­ °£ÀüÀÌ°¡ ÀÖ´Ù°í º¸°íµÈ´Ù. ÀÌ´Â ´ëÀåÀÇ Æ¯ÀÌÇÑ ÇغÎÇÐÀû
±¸Á¶ ¹× Á¾¾ç¼¼Æ÷ÀÇ Æ¯ÀÌÀû °£³» ÇÕÂø µîÀÌ °ü·ÃµÈ °ÍÀ¸·Î ¿¬±¸µÇ°í ÀÖ´Ù.
´ëÀå¾ÏÀÇ °£ÀüÀÌ¿¡ ´ëÇÑ Ä¡·á´Â ÀýÁ¦¼ú, ³Ãµ¿¼ö¼úÀ» Æ÷ÇÔÇÏ´Â ¼ö¼úÀûÄ¡·á¿Í Á¤¸Æ ȤÀº °£
µ¿¸ÆÀ» ÅëÇÑ Ç׾Ͼ๰¿ä¹ý, °£µ¿¸Æ»öÀü¿ä¹ý, ÇÇÇÏ¿¡Åº¿ÃÁÖ»ç µîÀÇ ºñ¼ö¼úÀûÄ¡·á°¡ Àִµ¥ ÁÖ
·Î ÀýÁ¦¼ú°ú Ç׾Ͼ๰¿ä¹ýÀÌ ÀÌ¿ëµÇ°í ÀÖ´Ù.
´ëÀå¾ÏÀÇ °£ÀüÀÌȯÀÚ¿¡¼­ ÀÚ¿¬°æ°ú³ª Ä¡·á°á°ú¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿¹ÈÄÀÎÀڵ鿡 ´ëÇÑ ¸¹Àº
¿¬±¸°¡ ÀÖ¾ú´Âµ¥ ÀϹÝÀûÀ¸·Î ¾Ë·ÁÁø ¿¹ÈÄÀÎÀÚ´Â ¼ºº°, ³ªÀÌ, ¿ø¹ß¾ÏÀÇ À§Ä¡, Ä¡·áÇüÅÂ, ÀýÁ¦
¼úÀÇ Á¾·ù, ÀýÁ¦¿¬ÀÇ °Å¸®, ¼úÀü Ç÷û CEA¼öÄ¡, ¿ø¹ß¾ÏÀÇ º´±â, ÀüÀ̾ÏÀÇ Å©±â ¹× ¼ýÀÚ, Àü
À̾ÏÀÇ ºÐÆ÷, ¿ø¹ß¾ÏÄ¡·áÈÄ ¹«º´±â°£ µîÀÌÁö¸¸ ÀÌ¿¡ ´ëÇÑ °á°ú´Â ´Ù¾çÇÏ°Ô º¸°íµÈ´Ù. º» ¿¬
±¸´Â ´ëÀå¾Ï °£ÀüÀ̽à ¾Ë·ÁÁø ¿¹ÈÄÀÎÀÚ Áß ÀǹÌÀÖ´Â ¿¹ÈÄÀÎÀÚ¸¦ °áÁ¤ÇÏ°í °£ÀýÁ¦±º¿¡¼­ ¿¹
ÈÄÀÎÀÚ¿¡ µû¸¥ »ýÁ¸À²À» ºñ±³ÇÏ¿© ¼ö¼ú ¹× ÃßÀûÁ¶»ç½Ã À¯ÀÇÇÏ¿©¾ß ÇÒ »çÇ×À» ÆľÇÇÏ°íÀÚ ÇÏ
¿´´Ù.

Purpose : Among various modalities of treatment in hepatic metastasis of colorectal
cancer, hepatic resection has been proven to be the most effective treatment. This
analysis was intended to determine important prognostic parameters and to understand
clinically significant factors during hepatic resection and follow-up period in patients
with hepatic metastasis from colorectal cancer.
Materials and Methods : Among 1,022 colorectal cancer patients treated at Asan
Medical Center from July 1989 to December 1995, 99 patients were found to have liver
metastasis at the time of first diagnosis or during follow-up period. These 99 patients
were the subject of analysis in this retrospective clinical study. Surgical resection with
curative intent was done in 35 patients and chemotherapy in 46 patients. Eighteen
patients were with no treatment or missed during follow-up. Survival rate was analysed
according to clinicopathological parameters: sex, age, location of primary tumor,
preoperative serum CEA level, TNM staging of primary tumor, number of hepatic
metastasis, distribution, synchronous or metachronous lesions, disease free interval, mode
of treatment, type of resection, tumor free resection margin.
Results : Overall survival of the patients with hepatic metastasis was significantly
related with numbers of metastasis (<4 vs. >4), distribution (unilobar vs. bilobar),
synchronous or metachronous lesions, disease free interval (<12 vs. >12 months), mode
of treatmeat (hepatic resection vs. chemotherapy vs. no treatment, p<0.01. A multivariate
analysis showed a significant association of survival with mode of treatment (p<0.01).
Survival of patients with hepatic resection was significantly related with resection
margin (positive vs. <1 §¯ vs. > 1 §¯), TNM staging of primary tumor (¥± vs. ¥²),
number of hepatic metastasis (p<0.01), disease free interval (p<0.05). A multivariate
analysis showed a significant correlation with survival for tumor free resection margin
(p<0.01).
Conclusion : An aggressive approach of hepatic resection in the colorectal liver
metastasis will improve survival, if the lesion _permits. In patients with hepatic
resection, tumor free resection margin was the most important prognostic parameter by
the uni- and multi-variate analysis. Therefore, every effort should be made to ensure
that the clear margin be kept at least more than 1 §¯ during hepatic resection.

Å°¿öµå

Colorectal cancer; Hepatic metastasis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS